BRAF and melanoma: Based on genomic analyses of the most prevalent mutations in the tumors (significantly mutated genes), the TCGA Research Network classified four molecular subtypes for melanoma patients: mutant BRAF, mutant RAS, mutant NF1, and Triple-Wildtype [29].